Search Results - Susan Bal
- Showing 1 - 9 results of 9
-
1
-
2
-
3
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy by Luciano J. Costa, Eva Medvedova, Binod Dhakal, Bhagirathbhai R. Dholaria, Kelly N. Godby, Susan Bal, Gayathri Ravi, Smith Giri, Saurabh Chhabra, Rebecca Silbermann, Natalie S. Callander
Published in Blood Cancer Journal (2025-02-01)Get full text
Article -
4
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy by Susan Bal, Tylan Magnusson, Gayathri Ravi, Smith Giri, Kelly Godby, Binod Dhakal, Natalie S. Callander, Rebecca W. Silbermann, Bhagirathbhai Dholaria, Vishnu B. Reddy, Luciano J. Costa
Published in Blood Cancer Journal (2025-04-01)Get full text
Article -
5
S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL by Luciano Costa, Eva Medvedova, Sarabh Chhabra, Bhagirathbhai Dholaria, Binod Dhakal, Kelly Godby, Rebecca Silberman, Susan Bal, Anita D’souza, Smith Giri, Timothy Schmidt, James Omel, Parameswaran Hari, Natalie Callander
Published in HemaSphere (2023-08-01)Get full text
Article -
6
Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta‐analysis by Nadia M. Anabtawi, Monica Sai Pasala, Alyssa A. Grimshaw, Prakash Kharel, Susan Bal, Kelly Godby, Ashmita Siwakoti, Thomas W. Buford, Smita Bhatia, Luciano J. Costa, Grant R. Williams, Smith Giri
Published in Journal of Cachexia, Sarcopenia and Muscle (2024-06-01)Get full text
Article -
7
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara‐KRd), autologous hematopoietic cell transplantation, and measur... by Rebecca W. Silbermann, Timothy Martin Schmidt, Susan Bal, Binod Dhakal, Bhagirathbhai Dholaria, Eden Biltibo, Saurabh Chhabra, Smith Giri, Kelly N. Godby, Sonia Gowda, Eva Medvedova, Robert F. Cornell, Natalie S. Callander, Luciano J. Costa
Published in eJHaem (2023-08-01)Get full text
Article -
8
S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FRO... by Susan Bal, Jesus Berdeja, Myo Htut, Mehmet Kocoglu, Tara Gregory, Larry D. Anderson, Adriana Rossi, Daniel Egan, Luciano Costa, Lisa Kelly, Safiyyah Ziyad, Hongxiang Hu, Yanping Chen, Allison J. Kaeding, Michael Burgess, Kristen Hege, Omar Nadeem
Published in HemaSphere (2023-08-01)Get full text
Article -
9
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk by Natalie S. Callander, Rebecca Silbermann, Jonathan L. Kaufman, Kelly N. Godby, Jacob Laubach, Timothy M. Schmidt, Douglas W. Sborov, Eva Medvedova, Brandi Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D. Anderson, Bhagirathbhai R. Dholaria, Nitya Nathwani, Parameswaran Hari, Nina Shah, Naresh Bumma, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Smith Giri, Luciano J. Costa, Saad Z. Usmani, Paul G. Richardson, Peter M. Voorhees
Published in Blood Cancer Journal (2024-04-01)Get full text
Article
